Login / Signup

Intra-arterial versus intravenous abciximab therapy for thromboembolic complications of neuroendovascular procedures: case review and meta-analysis.

Akash P KansagraJames D McEachernThomas P MadaelilAdam N WallaceDeWitte T CrossChristopher J MoranColin P Derdeyn
Published in: Journal of neurointerventional surgery (2016)
Abciximab produces a high rate of angiographic improvement and a low incidence of postprocedural infarct in neuroendovascular procedures complicated by thromboemboli. IA abciximab produces greater angiographic improvement than IV treatment. Postprocedural infarction is less common in patients with complete angiographic response than in those with partial or no response.
Keyphrases
  • risk factors
  • high dose
  • acute myocardial infarction
  • heart failure
  • coronary artery disease
  • low dose
  • left ventricular
  • percutaneous coronary intervention